A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS
Clinical trial NCT02269436 · TERMINATED
Trial details
- NCT number
- NCT02269436
- Sponsor
- Newron Sweden AB
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-10-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.